diphenhydramine has been researched along with Dermatitis, Atopic in 11 studies
Diphenhydramine: A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
diphenhydramine : An ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug.
antitussive : An agent that suppresses cough. Antitussives have a central or a peripheral action on the cough reflex, or a combination of both. Compare with expectorants, which are considered to increase the volume of secretions in the respiratory tract, so facilitating their removal by ciliary action and coughing, and mucolytics, which decrease the viscosity of mucus, facilitating its removal by ciliary action and expectoration.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Atopic dermatitis is the most common form of eczema, a condition that causes the skin to become itchy, dry and cracked." | 3.01 | Abrocitinib for the treatment of atopic dermatitis. ( Gooderham, M; Lé, AM; Torres, T, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Lé, AM | 1 |
| Gooderham, M | 1 |
| Torres, T | 1 |
| Papoiu, AD | 1 |
| Valdes-Rodriguez, R | 1 |
| Nattkemper, LA | 1 |
| Chan, YH | 1 |
| Hahn, GS | 1 |
| Yosipovitch, G | 1 |
| Murota, H | 1 |
| Bae, S | 1 |
| Hamasaki, Y | 1 |
| Maruyama, R | 1 |
| Katayama, I | 1 |
| Lin, TK | 1 |
| Man, MQ | 1 |
| Santiago, JL | 1 |
| Park, K | 1 |
| Roelandt, T | 1 |
| Oda, Y | 1 |
| Hupe, M | 1 |
| Crumrine, D | 1 |
| Lee, HJ | 1 |
| Gschwandtner, M | 1 |
| Thyssen, JP | 1 |
| Trullas, C | 1 |
| Tschachler, E | 1 |
| Feingold, KR | 1 |
| Elias, PM | 1 |
| SCHAFFER, K | 1 |
| Lawrence, CM | 1 |
| Byrne, JP | 1 |
| Zur, G | 1 |
| Ihrke, PJ | 1 |
| White, SD | 1 |
| Kass, PH | 1 |
| Jacobs, AH | 1 |
| Glukhen'kiĭ, BT | 1 |
| Grando, SA | 1 |
| Draelos, ZK | 1 |
| Hansen, RC | 1 |
| Davenport, PM | 1 |
| Wilhelm, RE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Skin Barrier Dysfunction and the Role of Skin Barrier Restoration on Cutaneous and Systemic Inflammation in the Aged Population[NCT03728569] | Early Phase 1 | 14 participants (Actual) | Interventional | 2018-05-16 | Terminated (stopped due to Enrollment and interactions/interventions paused due to COVID-19. Not expected to resume in the future. This is not a suspension of IRB approval) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for diphenhydramine and Dermatitis, Atopic
| Article | Year |
|---|---|
Abrocitinib for the treatment of atopic dermatitis.
Topics: Cytokines; Dermatitis, Atopic; Diphenhydramine; Double-Blind Method; Humans; Sulfonamides; Treatment | 2023 |
1 trial available for diphenhydramine and Dermatitis, Atopic
| Article | Year |
|---|---|
A novel topical formulation containing strontium chloride significantly reduces the intensity and duration of cowhage-induced itch.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Antipruritics; Chemistry, Pharmaceutical; De | 2013 |
9 other studies available for diphenhydramine and Dermatitis, Atopic
| Article | Year |
|---|---|
Emedastine difumarate inhibits histamine-induced collagen synthesis in dermal fibroblasts.
Topics: Benzimidazoles; Cells, Cultured; Collagen Type I; Dermatitis, Atopic; Diphenhydramine; Fibroblasts; | 2008 |
Topical antihistamines display potent anti-inflammatory activity linked in part to enhanced permeability barrier function.
Topics: Administration, Topical; Animals; Cell Differentiation; Cimetidine; Dermatitis, Atopic; Dermatitis, | 2013 |
[Experiences with systral ointment in allergic skin diseases].
Topics: Dermatitis; Dermatitis, Atopic; Dermatitis, Contact; Diphenhydramine; Ethylamines; Humans | 1957 |
Eczematous eruption from oral diphenhydramine.
Topics: Administration, Oral; Dermatitis, Atopic; Diphenhydramine; Female; Humans; Middle Aged; Nickel; Resp | 1981 |
Antihistamines in the management of canine atopic dermatitis: a retrospective study of 171 dogs (1992-1998).
Topics: Allergens; Animals; Chlorpheniramine; Clemastine; Dermatitis, Atopic; Diphenhydramine; Dog Diseases; | 2002 |
Management of atopic dermatitis in childhood.
Topics: Dermatitis, Atopic; Diphenhydramine; Drug Combinations; Fatty Alcohols; Humans; Propylene Glycols; S | 1975 |
[Suppression of the activity of biologically active substances for the relief of itching in atopic dermatitis].
Topics: Aminocaproates; Aminocaproic Acid; Dermatitis, Atopic; Diphenhydramine; Drug Therapy, Combination; H | 1985 |
Polymorphic light eruption in childhood.
Topics: Child; Dermatitis, Atopic; Diagnosis, Differential; Diphenhydramine; Drug Therapy, Combination; Halc | 1985 |
An unusual vasculitis due to diphenhydramine. Cutaneous and central nervous system involvement.
Topics: Adult; Black or African American; Dermatitis, Atopic; Diphenhydramine; Drug Eruptions; Drug Hypersen | 1965 |